Literature DB >> 19522654

Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States?

Joshua T Freeman1, Daniel J Sexton, Deverick J Anderson.   

Abstract

Community-onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli have become increasingly common worldwide but have been considered to be uncommon infections in the United States. We report the emergence and subsequent rapid increase in the incidence of these infections in community hospitals throughout North Carolina since 2006.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522654     DOI: 10.1086/600046

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.

Authors:  Joshua T Thaden; Sarah S Lewis; Kevin C Hazen; Kirk Huslage; Vance G Fowler; Rebekah W Moehring; Luke F Chen; Constance D Jones; Zack S Moore; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2014-06-20       Impact factor: 3.254

2.  Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method.

Authors:  Kenneth P Smith; Thea Brennan-Krohn; Susan Weir; James E Kirby
Journal:  J Clin Microbiol       Date:  2016-11-30       Impact factor: 5.948

3.  Biosensor diagnosis of urinary tract infections: a path to better treatment?

Authors:  Kathleen E Mach; Pak Kin Wong; Joseph C Liao
Journal:  Trends Pharmacol Sci       Date:  2011-03-31       Impact factor: 14.819

4.  Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains.

Authors:  Hajime Kanamori; Christian M Parobek; Jonathan J Juliano; James R Johnson; Brian D Johnston; Timothy J Johnson; David J Weber; William A Rutala; Deverick J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Localized effect of treated wastewater effluent on the resistome of an urban watershed.

Authors:  Christopher N Thornton; Windy D Tanner; James A VanDerslice; William J Brazelton
Journal:  Gigascience       Date:  2020-11-19       Impact factor: 6.524

6.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

7.  Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.

Authors:  Joshua T Thaden; Vance G Fowler; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-13       Impact factor: 3.254

8.  Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States.

Authors:  Luke F Chen; Joshua T Freeman; Brad Nicholson; Anna Keiger; Sarah Lancaster; Maria Joyce; Christopher W Woods; Evelyn Cook; Linda Adcock; Susan Louis; Andrea L Cromer; Daniel J Sexton; Deverick J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

Review 9.  The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world.

Authors:  Yohei Doi; Alina Iovleva; Robert A Bonomo
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

10.  Efficacy of combination use of Beta-lactamase inhibitor with penicillin and fluoroquinolones for antibiotic prophylaxis in transrectal prostate biopsy.

Authors:  Katsumi Shigemura; Minori Matsumoto; Kazushi Tanaka; Masuo Yamashita; Soichi Arakawa; Masato Fujisawa
Journal:  Korean J Urol       Date:  2011-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.